North York General Hospital researchers have developed an Enhanced First Trimester Screen that is faster, less costly, but just as accurate as the standard Integrated Prenatal Screening protocol in detecting the risk for Down syndrome and Trisomy 18. The new test was developed with the help of PerkinElmer and is now in use in Ontario, Canada.
Early screening for fetal abnormalities allows expectant parents to make healthcare decisions that may benefit the health of their baby.
Pre-eclampsia affects over 8 million women each year, and is a major cause of fetal and neonatal mortality. Risk screening can prevent or delay the disease.